Proinflammatory effects of resistin and anti-inflammatory effects of adiponectin have been shown in various metabolic and inflammatory diseases (atherosclerosis, diabetes mellitus, fatty liver disease, viral hepatitis), including patients with chronic hepatitis B [4], [5]. This evidence concerns the gene ADIPOQ and chronic hepatitis B virus infection.